371 related articles for article (PubMed ID: 25962989)
1. Objective Measurement of Arterial Flow Before and After Transcatheter Arterial Chemoembolization: A Feasibility Study Using Quantitative Color-Coding Analysis.
Lin YY; Lee RC; Tseng HS; Liu CA; Guo WY; Chang CY
Cardiovasc Intervent Radiol; 2015 Dec; 38(6):1494-501. PubMed ID: 25962989
[TBL] [Abstract][Full Text] [Related]
2. Quantitative Real-Time Fluoroscopy Analysis on Measurement of the Hepatic Arterial Flow During Transcatheter Arterial Chemoembolization of Hepatocellular Carcinoma: Comparison with Quantitative Digital Subtraction Angiography Analysis.
Lin YY; Lee RC; Guo WY; Chu WF; Wu FC; Gehrisch S
Cardiovasc Intervent Radiol; 2016 Nov; 39(11):1557-1563. PubMed ID: 27485268
[TBL] [Abstract][Full Text] [Related]
3. Three-Dimensional Quantitative Color-Coding Analysis of Hepatic Arterial Flow Change during Chemoembolization of Hepatocellular Carcinoma.
Lin EY; Lee RC; Guo WY; Wu FC; Gehrisch S; Kowarschik M
J Vasc Interv Radiol; 2018 Oct; 29(10):1362-1368. PubMed ID: 30170947
[TBL] [Abstract][Full Text] [Related]
4. Hepatic arterial damage after transarterial chemoembolization for the treatment of hepatocellular carcinoma: comparison of drug-eluting bead and conventional chemoembolization in a retrospective controlled study.
Lee S; Kim KM; Lee SJ; Lee KH; Lee DY; Kim MD; Kim DY; Kim SU; Won JY
Acta Radiol; 2017 Feb; 58(2):131-139. PubMed ID: 27217418
[TBL] [Abstract][Full Text] [Related]
5. Previous chemoembolization response after transcatheter arterial chemoembolization (TACE) can predict the anti-tumor effect of subsequent TACE with miriplatin in patients with recurrent hepatocellular carcinoma.
Imai N; Ikeda K; Seko Y; Kawamura Y; Sezaki H; Hosaka T; Akuta N; Kobayashi M; Saitoh S; Suzuki F; Suzuki Y; Arase Y; Kumada H
Oncology; 2011; 80(3-4):188-94. PubMed ID: 21709428
[TBL] [Abstract][Full Text] [Related]
6. Dense accumulation of lipiodol emulsion in hepatocellular carcinoma nodule during selective balloon-occluded transarterial chemoembolization: measurement of balloon-occluded arterial stump pressure.
Irie T; Kuramochi M; Takahashi N
Cardiovasc Intervent Radiol; 2013 Jun; 36(3):706-13. PubMed ID: 22996589
[TBL] [Abstract][Full Text] [Related]
7. Usefulness of cone-beam volume CT with flat panel detectors in conjunction with catheter angiography for transcatheter arterial embolization.
Kakeda S; Korogi Y; Ohnari N; Moriya J; Oda N; Nishino K; Miyamoto W
J Vasc Interv Radiol; 2007 Dec; 18(12):1508-16. PubMed ID: 18057285
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the relationship between hepatocellular carcinoma location and transarterial chemoembolization efficacy.
Miki I; Murata S; Uchiyama F; Yasui D; Ueda T; Sugihara F; Saito H; Yamaguchi H; Murakami R; Kawamoto C; Uchida E; Kumita SI
World J Gastroenterol; 2017 Sep; 23(35):6437-6447. PubMed ID: 29085193
[TBL] [Abstract][Full Text] [Related]
9. C-arm Lipiodol CT in transcatheter arterial chemoembolization for small hepatocellular carcinoma.
Li JJ; Zheng JS; Cui SC; Cui XW; Hu CX; Fang D; Ye LC
World J Gastroenterol; 2015 Mar; 21(10):3035-40. PubMed ID: 25780303
[TBL] [Abstract][Full Text] [Related]
10. Balloon-occluded arterial stump pressure before balloon-occluded transarterial chemoembolization.
Matsumoto T; Endo J; Hashida K; Mizukami H; Nagata J; Ichikawa H; Kojima S; Takashimizu S; Yamagami T; Watanabe N; Hasebe T
Minim Invasive Ther Allied Technol; 2016; 25(1):22-8. PubMed ID: 26406612
[TBL] [Abstract][Full Text] [Related]
11. Quantitative assessment of angiographic perfusion reduction using color-coded digital subtraction angiography during transarterial chemoembolization.
Wang J; Cheng JJ; Huang KY; Zhuang ZG; Zhang XB; Chi JC; Hua XL; Xu JR
Abdom Radiol (NY); 2016 Mar; 41(3):545-52. PubMed ID: 27039326
[TBL] [Abstract][Full Text] [Related]
12. Long-term outcome of transcatheter subsegmental and segmental arterial chemoemobolization using lipiodol for hepatocellular carcinoma.
Takaki S; Sakaguchi H; Anai H; Tanaka T; Yamamoto K; Morimoto K; Nishiofuku H; Inoue M; Sueyoshi S; Nagata T; Hidaka T; Uchida H; Kichikawa K
Cardiovasc Intervent Radiol; 2012 Jun; 35(3):544-54. PubMed ID: 21739345
[TBL] [Abstract][Full Text] [Related]
13. Feasibility of Intraprocedural Transluminal Hepatic and Femoral Artery Blood Pressure Measurements as an Alternative Embolization Safety Endpoint When Antireflux Devices Are Used During Lobar Chemoembolization.
Rose SC; Kikolski SG; Morshedi MM; Narsinh KH
AJR Am J Roentgenol; 2015 Jul; 205(1):196-202. PubMed ID: 26102399
[TBL] [Abstract][Full Text] [Related]
14. Angiographic evaluation of hepatic arterial damage after transarterial chemoembolization for hepatocellular carcinoma.
Maeda N; Osuga K; Mikami K; Higashihara H; Onishi H; Nakaya Y; Tatsumi M; Hori M; Kim T; Tomoda K; Nakamura H
Radiat Med; 2008 May; 26(4):206-12. PubMed ID: 18509720
[TBL] [Abstract][Full Text] [Related]
15. Transarterial chemoembolization with cisplatin as second-line treatment for hepatocellular carcinoma unresponsive to chemoembolization with epirubicin-Lipiodol emulsion.
Maeda N; Osuga K; Higashihara H; Tomoda K; Mikami K; Nakazawa T; Nakamura H; Tomiyama N
Cardiovasc Intervent Radiol; 2012 Feb; 35(1):82-9. PubMed ID: 21203761
[TBL] [Abstract][Full Text] [Related]
16. Transcatheter arterial chemoembolization with epirubicin-loaded superabsorbent polymer microspheres for 135 hepatocellular carcinoma patients: single-center experience.
Seki A; Hori S; Kobayashi K; Narumiya S
Cardiovasc Intervent Radiol; 2011 Jun; 34(3):557-65. PubMed ID: 20821211
[TBL] [Abstract][Full Text] [Related]
17. Interventional radiology for advanced hepatocellular carcinoma: comparison of hepatic artery infusion chemotherapy and transcatheter arterial lipiodol chemoembolization.
Sumie S; Yamashita F; Ando E; Tanaka M; Yano Y; Fukumori K; Sata M
AJR Am J Roentgenol; 2003 Nov; 181(5):1327-34. PubMed ID: 14573429
[TBL] [Abstract][Full Text] [Related]
18. Balloon-Occluded Transcatheter Arterial Chemoembolization (b-TACE) for Hepatocellular Carcinoma Performed with Polyethylene-Glycol Epirubicin-Loaded Drug-Eluting Embolics: Safety and Preliminary Results.
Lucatelli P; Ginnani Corradini L; De Rubeis G; Rocco B; Basilico F; Cannavale A; Nardis PG; Corona M; Saba L; Catalano C; Bezzi M
Cardiovasc Intervent Radiol; 2019 Jun; 42(6):853-862. PubMed ID: 30843093
[TBL] [Abstract][Full Text] [Related]
19. [Chemoembolization of hepatocellular carcinomas: which factors determine therapeutic response and survival?].
Huppert PE; Lauchart W; Duda SH; Torkler C; Kloska SP; Weinlich M; Benda N; Pereira P; Claussen CD
Rofo; 2004 Mar; 176(3):375-85. PubMed ID: 15026951
[TBL] [Abstract][Full Text] [Related]
20. Vascular complications of hepatic artery after transcatheter arterial chemoembolization in patients with hepatocellular carcinoma.
Sueyoshi E; Hayashida T; Sakamoto I; Uetani M
AJR Am J Roentgenol; 2010 Jul; 195(1):245-51. PubMed ID: 20566824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
